AXXE – Is My HUGE New Breakout Play!

EquityTradingAlert Newsletter

AXXE Is On HIGH ALERT! Dear Valued Member, On The Heels of hugely successful picks like ITGC that ran up +400%, we could not be more excited to bring our members our next ALERT! My HUGE New Breakout Play is:

Axxess Pharma, Inc. (AXXE) Symbol: AXXE Co: Axxess Pharma, Inc.

Website: www.axxesspharmainc.com AXXE Is On Immediate ALERT! About Axxess Pharma, Inc.

Axxess Pharma, Inc. is a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products in niche markets. Although they serve the General Practice market, Axxess Pharma, Inc. also distributes products that target Dermatology, Rheumatology, Gynecology, Urology and Nephrology markets.

My new Alert needs to be on your radar immediately as the ultimate ground-floor opportunity. There is so much to get excited about so let`s get started.

This Company already has a “cash cow” in its popular TapouT product line, having sold and even sold out on Amazon .com, the largest worldwide online retailer.

Last year AXXE signed an agreement providing Axxess Pharma the world-wide exclusive rights, to develop, market and sell a line of pain relief and muscle recovery products, as well as develop and market a vitamins and minerals line under the TapouT brand name.

The TapouT brand is highly recognized and respected within the Mixed Martial Arts (MMA) community. MMA is better known as the UFC.

The brand has been connected to UFC pretty much since it came around back in the late 90s.

TapouT has also endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, but most famously, MMA. Millions of customers from around the world visit TapouT.com each month.

Tapout.com was the first website offering AXXE`s line of topical pain relief and muscle recovery products to go along with its own core offerings. (Many more outlets are selling products now!) The company`s product line was originally developed with mixed martial arts fighters in mind, but quickly became popular with serious athletes across a wide variety of sports.

In just a short period of time, UFC has grown into an enterprise valued at $2 billion, rivaling the market worth of the NFL`s Dallas Cowboys or Major League Baseball`s New York Yankees.

UFC content is already broadcast by more than 30 TV networks in 28 languages in 145 nations with a potential of more than 800 million viewing households! With this kind of coverage what do you think this could do for AXXE There`s no telling where AXXE will be in the near term!! AXXE has taken some HUGE steps forward recently, placing the Company in an excellent position for growth. They have released quite a few significant press releases all of which indicate the Company`s Huge Growth potential! AXXE recently announced that they have entered into the $1 billion US Omega-3 oil market, which it anticipates generating significant residual revenues from.

AXXE is now showing the kind of growth potential that we must pay attention to because it`s unlikely they can stay here at these levels for much longer.

Because of this…

AXXE has been dominating the headlines in recent weeks, announcing on May 1 the world-wide purchase order from the US Military for its TapouT line of pain relief and muscle growth products.

Which AXXE announced on June 12th that they have delivered on its initial order to the Army Air Force Exchange Service (AAFES), valued at almost $30,000.

And that was just the warming up phase. AXXE has taken some HUGE steps forward recently, from there announcement that they received an award from the United States Trade and Commerce Institute to their announcement of a new distribution partner and signed UFC Octagon Girl Brittney Palmer to its team of spokespersons to the world-wide purchase order from the US Military.

AXXE has been extremely busy…

As you can imagine, such high levels of activity means Wall Street has no choice but to take notice and AXXE looks to be setting up for a major breakout! AXXE Market Opportunity:

While the Company has a range of products in the pipeline, the near term focus for AXXE is their TapouT brand of vitamins and minerals, pain relief and muscle recovery products.

Following are select highlights regarding the market with relevance for AXXE`s planned operations:

-Global Industry Analysts, Inc. (GIA) forecasts the Pain Management market to reach $77BB by 2017.

-MusclePharm (OTC: MSLP) sales from 2010 – 2012 were $3.2MM, $17.2MM, $67MM. The Company`s gross margin increased from 5% to 30% during that time. At a recent price of $9.82, MSLP is trading at approximately 1x revenue for the trailing twelve months.

-Glanbia PLC Estimates the Global Sports Nutrition market is $6 billion ($4 billion U.S.) -Vestcom Estimates the Vitamin / Mineral / Supplement Market is $30 billion in the U.S -GNC expects the US Dietary Supplement market to reach nearly $40 billion by 2015.

-Vitamin Shoppe estimates the 4 largest specialty supplements chains have a combined 12.3% market share in a highly fragmented market.

These are huge numbers and big shoes to fill but AXXE realizes that just a small percentage of market share could put the company into a good position to succeed.

AXXE could be a very attractive buy out candidate to huge players within the sector! I recommend starting your own research on AXXE right away.

As always we encourage all of our subscribers to complete their own due diligence and visit the company website: www.axxesspharmainc.com As always do your own research, book profits when you are in a position to do so, and always trade with stop loss orders to protect yourself if the trade goes against us.

Sincerely, Air Goldstein Editor In Chief, EquityTraingAlert Sincerely, Ari Goldstein Editor In Chief, EquityTradingAlert DON`T MISS ANOTHER HOT OPPORTUNITY TO MAKE HUGE PROFITS! GENERAL NOTICE AND DISCLAIMER – PLEASE READ CAREFULLY This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. The companies that are discussed on EquityTradingAlert.com have not approved the statements made. This opinion contains forward-looking statements that involve risks and uncertainties. A company`s actual results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for nformational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. EquityTradingAlert.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, or employees. Please consult a broker before purchasing or selling any securities viewed on EquityTradingAlert.com. EquityTradingAlert.com or mentioned herein. Affiliates, officers, directors and employees of EquityTradingAlert.com may have also bought or may buy shares of companies mentioned herein and may profit in the event those shares rise in value. EquityTradingAlert.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make their own decision based on his or her judgment of the market. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser or broker prior to completing any such purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies.

Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in private transactions. These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions. Reading this advertisement shall not create under any circumstances an offer to buy or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. Void where prohibited. Information within this advertisement contains “forward looking” statements within the meaning of Section 27 (a) of the U.S. Securities A-c-t of 1-9-3-3 and Section 21(e) of the U.S. Securities Exchange A-c-t of 1-9-3-4. Neither EquityTradingAlert.com, its officers, affiliates or employees is a broker-dealer. The information on EquityTradingAlert.com, including the opinions expressed and the statements made within, is for informational and advertising purposes only and should not be construed as investmentadvic, and does not constitute an offer to sell any securities, nor is it to be construed as a solicitation to purchase any securities in any state or other jurisdiction where the offer or sale is not permitted. The information to prepare this report is believed to be from reliable sources, but no representation is made as to the accuracy or completeness of such information. Investment in securities carries a high degree of risk and involves risks and uncertainties, which may result in investors losing all of their invested capital. Past performance does not guarantee future results. The information contained herein contains “forward-looking statements,” within the meaning of Section 27 A of the Securities A-c-t of 1-9-3-3 and Section 21 E of the Securities Exchange A-c-t of 1-9-3-4. Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur. Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense competition, lack of meaningful research results, inadequate capital, termination of contracts or agreements, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in the reports filed with the Securities and Exchange Commission by the companies who are mentioned in this periodical. Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein. More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at http://clicks.aweber.com/y/ct/l=Hkg1R&m=JTohFXpAfHtRB1&b=qszuUcPmGO0wUo_EqeeyVg, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.

BUYING AND SELLING OF SHARES EquityTradingAlert.com intends to sell its shares.

EquityTradingAlert.com may sell its shares for less than target prices given in opinions. EquityTradingAlert.com affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value. EquityTradingAlert.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. There are risks involved Always remember that EquityTradingAlert.com are not analysts and investing in securities such as the ones listed within are for high risk tolerant individuals only and not the general public. Whether you are an experienced investor or not you should always consult with a broker before purchasing or selling any securities viewed on EquityTradingAlert.com. If at any time you wish to be removed from our list simply

Related posts:

1. AXXE me about Monday’s MAJOR Winner….Go ahead<<<
2. Focus on AXXE on Thursday; MAJOR update
3. AXXE is my new pick. Did you miss my last high flying alert? Read now.
4. ***My Incredible Winning Streak Set to Continue***
5. Urgent Reminder- Huge New Breakout Play Coming TUESDAY 4PM!